Each of these presentations adds to the growing body of evidence in favor of cefepime-enmetazobactam to treat infections by third-generation cephalosporin (3GC)-resistant Enterobacteriaceae
, the most prevalent 'critical priority' pathogen as defined by the WHO," said Klaus Wilgenbus, Chief Executive Officer of Allecra Therapeutics.
cloacae which are members of Enterobacteriaceae
family play a significant role in causing nosocomial infections like, wounds, skin, soft tissue, urinary tract, respiratory tract, and biliary tract, mostly in immunocompromised patients.
VenatoRx believes that VNRX-5133, in a fixed combination with the fourth generation cephalosporin, cefepime, has the potential to provide a valuable broad-spectrum treatment option to meet unmet medical needs in patients with infections due to carbapenem-resistant pathogens including carbapenem-resistant Enterobacteriaceae
and carbapenem-resistant Pseudomonas aeruginosa (CRPA), suspected polymicrobial infections caused by both gram-negative and gram-positive susceptible pathogens, and engineerable bioterror pathogens such as Burkholderia spp.
We also reported encouraging topline data from the Phase 1 study of ETX0282 which is being developed as a therapy for gram-negative infections caused by multidrug-resistant Enterobacteriaceae
. We also announced the addition of David Meek, current CEO of Ipsen S.A.
Summary: These tests are easy to perform and can be performed in a routine laboratory, which makes them more feasible and thus, one of the leading test types in Carbapenem-resistant enterobacteriaceae
In a recent study, scientists have discovered that three closely related species of bacteria belonging to the family Enterobacteriaceae
, known to cause infection in hospitals, outlived all other oral bacteria in long-term starvation or 'doomsday' experiment.
is the primary pathogen isolated among gram negatives.
Wenjing Wu found two unknown species of Enterobacteriaceae
in two different patients.
Helperby recently presented data at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) announcing Phase I results on the tolerability, pharmacokinetics and pharmacodynamics of AZT and colistin both alone and as a combined therapy, against multi-drug resistant Enterobacteriaceae
(CRE), one of the most serious drug resistant pathogens.
family contains a large number of species that are causes for most common infections like nosocomial infections, urinary tract and wound infections, pneumonia, meningitis and septicemia (Ruiz et al., 2002).
Karbapeneme direncli Enterobacteriaceae
ailesine ait turler dunyanin her yerinde giderek artan siklikta bildirilmektedir.